#4408 ASSOCIATION BETWEEN CKD-MBD AND SYMPTOM BURDEN IN OLDER PATIENTS WITH ADVANCED CKD – RESULTS FROM THE EQUAL STUDY
Lorenza Magagnoli(AOL (United States)), Kitty J. Jager(Amsterdam University Medical Centers), Claudia Torino(Istituto di Fisiologia Clinica), Christoph Wanner(Universitätsklinikum Würzburg), Marie Evans(Karolinska University Hospital), Mario Cozzolino(AOL (United States)), Maciej Szymczak(Wroclaw Medical University), Friedo W. Dekker(Leiden University Medical Center), Fergus Caskey, Nicholas C Chesnaye(Amsterdam Neuroscience)
Cited by 0
Related Papers
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|969
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
An introduction to inverse probability of treatment weighting in observational research
|Clinical Kidney Journal|2021|877